| Financial Year |
March 31 2023 |
| Monetary Funds |
24,664,557.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
183,936,720.94 |
| Advances to Suppliers |
24,978,759.69 |
| Other Receivables |
39,862,761.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
62,061,799.12 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
326,541.65 |
| Total Current Assets |
344,921,973.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
278,597,222.44 |
| Under-construction Projects |
469,724.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
123,912,563.60 |
| R&D expenses |
6,736,329.00 |
| Goodwill |
10,737,687.68 |
| Long-Term Deferred and Prepaid Expenses |
7,254,536.83 |
| Deferred Income Tax Assets |
46,855,086.74 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
497,883,585.40 |
| Total Assets |
842,805,559.01 |
| Short-Term Loans |
122,781,603.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
99,132,278.76 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,614,236.34 |
| Taxes Payable |
23,301,846.02 |
| Interest Payable |
353,937.94 |
| Dividend Payable |
-- |
| Other payables |
51,201,841.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,215,525.54 |
| Other Current Liabilities |
2,055,869.20 |
| Sub-Total of Current Liabilities |
456,944,276.23 |
| Long-term Loans |
126,060,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,434,551.60 |
| Deferred Income Tax Liabilities |
2,764,625.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
142,730,533.04 |
| Total Liabilities |
599,674,809.27 |
| Paid-In Capital(Or Share Stock) |
205,135,376.00 |
| Capital Surplus |
120,769,855.43 |
| Surplus Reserve |
21,201,618.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-277,973,968.19 |
| Minority Stockholder's Interest |
173,997,868.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
69,132,881.67 |
| Owner's Equity（Stockholder's Equity） |
243,130,749.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
842,805,559.01 |
